Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adagio Medical Holdings (ADGM) Equity Average (2023 - 2026)

Adagio Medical Holdings has reported Equity Average over the past 4 years, most recently at $9.1 million for Q1 2026.

  • Quarterly Equity Average fell 43.9% to $9.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Mar 2026, down 43.9% year-over-year, with the annual reading at $16.2 million for FY2025, 128.82% up from the prior year.
  • Equity Average was $9.1 million for Q1 2026 at Adagio Medical Holdings, up from $5.5 million in the prior quarter.
  • Over five years, Equity Average peaked at $48.2 million in Q4 2024 and troughed at -$139.9 million in Q2 2024.
  • The 4-year median for Equity Average is $4.6 million (2025), against an average of -$34.2 million.
  • Year-over-year, Equity Average surged 137.75% in 2024 and then tumbled 88.5% in 2025.
  • A 4-year view of Equity Average shows it stood at -$127.8 million in 2023, then surged by 137.75% to $48.2 million in 2024, then tumbled by 88.5% to $5.5 million in 2025, then surged by 63.45% to $9.1 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Equity Average are $9.1 million (Q1 2026), $5.5 million (Q4 2025), and $3.7 million (Q3 2025).